"Auto\u0159i shrnuj\u00ED dosavadn\u00ED poznatky o l\u00E9\u010Db\u011B shcizoafektivn\u00ED a bipol\u00E1rn\u00ED poruchy. U obou nozologick\u00FDch jednotek je \u010Dasto prvn\u00ED volbou kombinace stabiliz\u00E1tor\u016F a antipsychotik, respektive antidepresiv. V 70. letech bylo v pop\u0159ed\u00ED z\u00E1jmu lithium, v 80. letech antikonvulziva a 90. l\u00E9ta jsou charakterizov\u00E1na n\u00E1stupem atypick\u00FDch antipsychotik. Nen\u00ED zcela jsn\u00E9, zda atypick\u00E1 antipsychotika jsou stabiliz\u00E1tory n\u00E1lady, proto\u017Ee chyb\u00ED dostatek studi\u00EDl Auto\u0159i d\u00E1le uv\u00E1d\u011Bj\u00ED vlastn\u00ED zku\u0161enosti s l\u00E9\u010Dbou schizoafektivn\u00ED poruchy. Na z\u00E1klad\u011B retorspektivn\u00ED anal\u00FDzy chorobopisn\u00E9ho materi\u00E1lu zjistili, \u017Ee v t\u00E9to indikaci byla preferov\u00E1na antipsychotika. Se stabiliz\u00E1tory n\u00E1lady p\u0159ich\u00E1zel 20/64 (31%) pacient\u016F, ouze 3/20 (15%) m\u011Blo monoterapii a vz\u00E1jemnou kombinaci kombinaci stabiliz\u00E1tor\u016F. Atypick\u00E1 antipsychotika p\u0159eva\u017Eovala 46/64 (72%) nad klasick\u00FDmi antipsychotiky (21/46, 46%), toto rozlo\u017Een\u00ED bylo zachov\u00E1no i p\u0159i propu\u0161t\u011Bn\u00ED. P\u0159i propu\u0161t\u011Bn\u00ED odch\u00E1zelo v\u00EDce nemocn\u00FDch s antipsychotiky (13% vs 22%). Nej\u010Dast\u011Bji aplikovan\u00FDm antipsychotik"@cs . . . "Auto\u0159i shrnuj\u00ED dosavadn\u00ED poznatky o l\u00E9\u010Db\u011B shcizoafektivn\u00ED a bipol\u00E1rn\u00ED poruchy. U obou nozologick\u00FDch jednotek je \u010Dasto prvn\u00ED volbou kombinace stabiliz\u00E1tor\u016F a antipsychotik, respektive antidepresiv. V 70. letech bylo v pop\u0159ed\u00ED z\u00E1jmu lithium, v 80. letech antikonvulziva a 90. l\u00E9ta jsou charakterizov\u00E1na n\u00E1stupem atypick\u00FDch antipsychotik. Nen\u00ED zcela jsn\u00E9, zda atypick\u00E1 antipsychotika jsou stabiliz\u00E1tory n\u00E1lady, proto\u017Ee chyb\u00ED dostatek studi\u00EDl Auto\u0159i d\u00E1le uv\u00E1d\u011Bj\u00ED vlastn\u00ED zku\u0161enosti s l\u00E9\u010Dbou schizoafektivn\u00ED poruchy. Na z\u00E1klad\u011B retorspektivn\u00ED anal\u00FDzy chorobopisn\u00E9ho materi\u00E1lu zjistili, \u017Ee v t\u00E9to indikaci byla preferov\u00E1na antipsychotika. Se stabiliz\u00E1tory n\u00E1lady p\u0159ich\u00E1zel 20/64 (31%) pacient\u016F, ouze 3/20 (15%) m\u011Blo monoterapii a vz\u00E1jemnou kombinaci kombinaci stabiliz\u00E1tor\u016F. Atypick\u00E1 antipsychotika p\u0159eva\u017Eovala 46/64 (72%) nad klasick\u00FDmi antipsychotiky (21/46, 46%), toto rozlo\u017Een\u00ED bylo zachov\u00E1no i p\u0159i propu\u0161t\u011Bn\u00ED. P\u0159i propu\u0161t\u011Bn\u00ED odch\u00E1zelo v\u00EDce nemocn\u00FDch s antipsychotiky (13% vs 22%). Nej\u010Dast\u011Bji aplikovan\u00FDm antipsychotik" . "Ka\u0161p\u00E1rek, Tom\u00E1\u0161" . . . "polypharmacotherapy; schizoaffective disorder; bipolar disorder; combinations with mood stabilizers; atypical antipsychotics"@en . . "Z(MSM 141100001)" . . . . "\u010Cesk\u00E1 a slovensk\u00E1 psychiatrie" . . "polypharmacotherapy - when is it Treatment of the First or Second Choice? part I."@en . "RIV/00216224:14110/03:00009286" . "2"^^ . "RIV/00216224:14110/03:00009286!RIV09-MSM-14110___" . "Data about treatment of schizoaffective and bipolar disorders are summarised. In both disorders the frequent first choice is the combination of mood stabilizers and antipsychotics, respective antidepressants. In th 70's lithium was very popular, in the 80's anticonvulsants appeared and in the 90's atypical antipsychotics started to bi in the focus of attention. It is not clear whether atypical antipsychotics are mood stabilizers, because there is a lack of adequate studies. The authors data about the treatment of schizoffective disorders are presented. The authors, using retrospective chart analysis, found taht in this indication antipsychotics were preferred. On admission mood stabilizers were used in 20/64 (31%), only in 3/20 (15%) as monotherapy and in combination, in 46/64 (72%) antipsychotics were used. Atypical antipsychotics were preferre(33/46, 72%)to conventional antipsychotics (21/46, 46%). This ratio persisted on discharge. On discharge a higher number of patients were treated with antipsyc"@en . "Kdy je polyfarmakoterapie l\u00E9\u010Dbou prvn\u00ED nebo druh\u00E9 volby - I. \u010D\u00E1st"@cs . . "CZ - \u010Cesk\u00E1 republika" . . "2"^^ . "Kdy je polyfarmakoterapie l\u00E9\u010Dbou prvn\u00ED nebo druh\u00E9 volby - I. \u010D\u00E1st"@cs . "Kdy je polyfarmakoterapie l\u00E9\u010Dbou prvn\u00ED nebo druh\u00E9 volby - I. \u010D\u00E1st" . . "polypharmacotherapy - when is it Treatment of the First or Second Choice? part I."@en . "612145" . . . "1212-0383" . . . "\u010Ce\u0161kov\u00E1, Eva" . "3" . "14110" . "Kdy je polyfarmakoterapie l\u00E9\u010Dbou prvn\u00ED nebo druh\u00E9 volby - I. \u010D\u00E1st" . . "99" . "8"^^ . "[507B0283592D]" . .